ClinicalTrials.gov
public full text
Public Domain
Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis
This study is to evaluate the efficacy of ultraviolet-A (UVA) and riboflavin application (also often referred to as corneal collagen crosslinking) as a method to enhance treatment of infectious keratitis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas#1282355
- Effectiveness of Corneal Accelerated Crosslinking for Infectious Keratitis#1101158
- Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas#1087800
- Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas (2)#1138628
- Clinical and Structural Outcome of Conventional Versus Accelerated Corneal Collagen Cross-linking (CXL).#842789
Record · ID 1382134
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive